AIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company is headquartered in Carlsbad, California.
| Revenue (TTM) | $4.31M |
| Gross Profit (TTM) | 436,460 |
| EBITDA | $-11.16M |
| Operating Margin | -382.10% |
| Return on Equity | -237.00% |
| Return on Assets | -42.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.75 |
| Price-to-Book | 2.38 |
| Price-to-Sales (TTM) | 6.44 |
| EV/Revenue | 0.685 |
| EV/EBITDA | -0.05 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $20.23M |
| Float | $18.56M |
| % Insiders | 6.41% |
| % Institutions | 0.29% |